Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-12

Clinical Trial Update: Sleep and Immunity in Rheumatoid Arthritis : Remicade Substudy [NA]

View source ↗

Summary

Clinical trial update reporting results from a Remicade (infliximab) substudy in rheumatoid arthritis; the study is completed and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remicade (infliximab)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Rheumatoid Arthritis | NA | Status: COMPLETED | Results posted: 2017-09-12